Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Galletta · SciRah

Researcher profile · Semantic Scholar

L. Galletta

Share profile

L. Galletta — researcher profile on SciRah

h-index: 13
Works: 23
Citations: 3,501

Most-cited papers

ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
K. Wiegand, Sohrab P. Shah, O. Al-Agha, Yong-Jun Zhao +40 more
2010New England Journal of Medicine1,681 citations Open access
Semantic Scholar
Associations between hormone receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
W. Sieh, M. Köbel, T. Longacre, D. Bowtell +63 more
2013The Lancet Oncology394 citations Open access
Semantic Scholar
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
O. Kondrashova, M. Topp, K. Nešić, Elizabeth Lieschke +178 more
2018Nature Communications293 citations Open access
Semantic Scholar
A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment
H. Kulbe, P. Chakravarty, D. A. Leinster, Kellie A. Charles +13 more
2011Cancer Research214 citations Open access
Semantic Scholar
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
M. Anglesio, S. Kommoss, M. Tolcher, B. Clarke +21 more
2013Journal of Pathology205 citations Open access
Semantic Scholar
Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts
M. Topp, L. Hartley, M. Cook, V. Heong +18 more
2014Molecular Oncology142 citations Open access
Semantic Scholar
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
M. Köbel, J. Madore, S. Ramus, B. Clarke +58 more
2014British Journal of Cancer105 citations Open access
Semantic Scholar
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.
P. Cowin, J. George, S. Fereday, E. Loehrer +19 more
2012Cancer Research103 citations Open access
Semantic Scholar
Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver
C. Emmanuel, Y. Chiew, J. George, D. Etemadmoghadam +22 more
2014Clinical Cancer Research102 citations
Semantic Scholar
Efficient molecular subtype classification of high‐grade serous ovarian cancer
H. S. Leong, L. Galletta, D. Etemadmoghadam, J. George +3 more
2015Journal of Pathology92 citations Open access
Semantic Scholar
The Australian Ovarian Cancer Study
N. Traficante, S. Fereday, L. Galletta, J. Hung +9 more
2012Hereditary Cancer in Clinical Practice76 citations Open access
Semantic Scholar
Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer
B. Gao, Amanda J. Russell, J. Beesley, Xiao-Qing Chen +13 more
2014Scientific Reports34 citations Open access
Semantic Scholar
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427)
T. Pham, L. Pereira, S. Roth, L. Galletta +9 more
2019Contemporary Clinical Trials Communications27 citations Open access
Semantic Scholar
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
K. Nešić, J. Krais, Yi-Fan Wang, Cassandra J. Vandenberg +185 more
2024Molecular Cancer12 citations Open access
Semantic Scholar
Research priorities for the most premature babies born <25 weeks’ gestation: results of an international priority setting partnership
S. Peart, O. Ray, L. Galletta, A. Bates +16 more
2025Archives of Disease in Childhood10 citations Open access
Semantic Scholar
Biology of Human Tumors Genomic Classi fi cation of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP 53-Mutant Tumors and Identi fi es NRAS as an Oncogenic Driver
C. Emmanuel, Y. Chiew, J. George, D. Etemadmoghadam +22 more
20149 citations
Semantic Scholar
Pembrolizumab and chemoradiotherapy for muscle invasive bladder cancer: The ANZUP 1502 PCR-MIB trial.
A. Weickhardt, F. Foroudi, S. Sengupta, L. Galletta +13 more
20183 citations
Semantic Scholar
Molecular and Cellular Pathobiology LRP 1 B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal Doxorubicin
P. Cowin, J. George, S. Fereday, E. Loehrer +19 more
20122 citations
Semantic Scholar
Positive end-expiratory pressure levels during resuscitation of preterm infants at birth (POLAR): study protocol for a randomised controlled trial.
D. Tingay, L. Galletta, L. Owen, O. Kamlin +16 more
2026Pediatric Research1 citations Open access
Semantic Scholar
Pembrolizumab with ChemoRadiotherapy for Muscle Invasive Bladder Cancer: the ANZUP PCR-MIB trial
A. Weickhardt, F. Foroudi, S. Sengupta, P. Grimison +14 more
20160 citations Open access
Semantic Scholar
ANZUP Fellowships and Awards
A. Azard, Sanjeev Bandi, Philip Bredin, Megan Crumbaker +29 more
2016Asia-Pacific Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Abstract 38: Using molecularly characterized patient-derived models to delineate underlying drivers and vulnerabilities of epithelial ovarian cancer
M. Topp, L. Hartley, M. Cook, V. Heong +18 more
20140 citations
Semantic Scholar
The Australian Ovarian Cancer Study
N. Traficante, S. Fereday, L. Galletta, J. Hung +9 more
2012Hereditary Cancer in Clinical Practice0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Fereday×12
Invite
S. Fereday — researcher profile on SciRah
D. Bowtell×10
Invite
D. Bowtell — researcher profile on SciRah
A. deFazio×9
Invite
A. deFazio — researcher profile on SciRah
M. Anglesio×8
Invite
M. Anglesio — researcher profile on SciRah

×7

Invite

J. George — researcher profile on SciRah

D. Etemadmoghadam×7

Invite

D. Etemadmoghadam — researcher profile on SciRah

Invite

J. Hendley — researcher profile on SciRah

Invite

P. Harnett — researcher profile on SciRah

Invite

O. McNally — researcher profile on SciRah

Invite

K. Alsop — researcher profile on SciRah

Invite

J. Hung — researcher profile on SciRah

N. Traficante×4

Invite

N. Traficante — researcher profile on SciRah